Advanced search
1,301
Views
4
CrossRef citations to date
0
Altmetric
Articles

IL2 is required for functional maturation of regulatory T cells

&
Pages 1-9
Received 17 Nov 2016
Accepted 06 Dec 2016
Published online: 30 Dec 2016

ABSTRACT

Regulatory T cells (Tregs), specified by the expression of transcription factor Foxp3, operate Foxp3-dependent programs to maintain self-tolerance. In addition to Foxp3, other tissue-specific transcription factors are also required by Tregs to control the corresponding immune responses like follicular Tregs which express both Foxp3 and Bcl6 controlling germinal center reactions. Here, we show that Interleukin 2 (IL2) is required for the optimal expression of T helper type 1 (Th1) transcription factor T-box 21 (Tbx21, T-bet) in Tregs. The expression levels of CXCR3 and T-bet were reduced in IL2 deficient Tregs. Furthermore, IL2 deficient Treg cells failed to control the proliferation of CD4+ T cells in vitro and could not prevent the progression of colitis characterized by Th1 immune responses. Taken together, our data suggest that IL2 is essential for the functional maturation of Tregs including the optimal suppressive activity and the expression of tissue-specific transcription factors like T-bet.

Introduction

Forkhead box P3+ (Foxp3+) regulatory T cells (Tregs) are a dedicated cell population that maintains immune tolerance (Sakaguchi et al. 2008). This is exemplified by the severe autoimmunity in mice carrying the scurfy mutation of the Foxp3 alleles (Brunkow et al. 2001; Wildin et al. 2001). In addition to preventing autoimmunity, Tregs are also involved in protective immunity against pathogens (Belkaid 2007) and suppress anti-tumor immune responses as well (Savage et al. 2013). To function under such diverse conditions, Tregs are equipped with a wide variety of cellular and molecular effectors including cytokines (Rubtsov et al. 2008), cytolysis (Cao et al. 2007) and surface inhibitors (Wing et al. 2014). Furthermore, Tregs co-opt transcription factors critical for T helper (Th) cell differentiation like T-box 21 (Tbx21, T-bet), IRF4, STAT3 and Bcl6 to regulate the corresponding immune responses and show extensive phenotypic and genetic heterogeneity (Chaudhry et al. 2009; Koch et al. 2009; Zheng et al. 2009; Campbell & Koch 2011; Cipolletta et al. 2012; Fu et al. 2012). For example, T-bet is the transcription factor regulating the differentiation of Th type 1 (Th1) cells that produce interferon-gamma (IFN-γ) and coordinate the immune responses against intracellular pathogens. However, T-bet is expressed in Tregs as well in an IFN-γ dependent manner and required for the survival of Tregs in Th1 environments (Koch et al. 2009). Currently, it is still unclear which factor(s) other than IFN-γ is involved in the expression of the above Th transcription factors in Tregs.

Interleukin 2 (IL2) has dual and sometimes opposing roles in immune responses contributing to the generation of effector/memory T cells, anti-tumor immunity (Choi et al. 2008), and the maintenance of Tregs (Malek & Castro 2010). However, the observation that Il2−/− mice develop autoimmune diseases led us to realize that the non-redundant function of IL2 is to maintain Tregs. Many studies indicate that IL2 provides essential signals to Tregs at least two different levels: (1) thymic development (Cheng et al. 2013) and (2) peripheral homeostasis and competitive fitness (Malek 2008; Cheng et al. 2011). However, the role of IL2 in the heterogeneity of Tregs remains unclear.

In this study, we found that the frequency of Tregs expressing CXCR3 (Th1 chemokine receptor) and/or T-bet was significantly reduced in Il2−/− mice. These results prompted us to hypothesize that IL2 is essential for the generation of T-bet+ Tregs and contributes to the suppressive activity in Th1-dominant environments. Indeed, we found that the expression of T-bet was controlled by IL2, and STAT5 binds to the T-bet promoter locus in Tregs suggesting that IL2 and its adaptor molecule STAT5 regulate the expression of T-bet directly and help Tregs to control immune responses in Th1 type inflammations.

Materials and methods

Mice

CD45.1 congenic (B6.SJL-Ptprca Pepcb/BoyJ), Rag1 deficient (Rag1−/−, CD45.2, B6), IL2 deficient (Il2−/−, B6.129P2-Il2tm1Hor/J, CD45.2) and Foxp3-GFP knock-in (Foxp3 bicistronic reporter mice expressing EGFP: B6.Cg-Foxp3tm2Tch/J, CD45.2) mice were obtained from The Jackson Laboratory (Bar Harbor, ME, USA). Mice were all in the C57BL/6 (B6) background and bred in the animal facility at the Hallym University. Since the phenotypes of Il2−/− mice are characterized by prominent inflammatory responses (Schorle et al. 1991) and these phenotypic changes can affect the physiology of Tregs (Fontenot et al. 2005), we tried to use young wild type (WT) and Il2−/− mice where inflammation did not start yet or was mild (8−15 days of age unless otherwise specified in the text or figure legends). Foxp3-GFP knock-in allele(s) was introduced into all genetically modified mice by mating and GFP signals were used to identify Tregs. Animal experimentations were conducted in accordance with the guidelines of the Experimental Animal Center at Hallym University (Hallym 2012-61-1, 2013-109).

Cell isolation and flow cytometry

To sort peripheral T cell subpopulations from spleens and lymph nodes (LNs), the CD4+ fraction was first purified on the MACS using anti-CD4 beads (Miltenyi Biotec, Bergisch Gladbach, Germany). The enriched CD4+ fractions were then further separated into each subpopulation by using FACS Aria-II flow cytometer (BD Biosciences, San Jose, CA, USA). To sort naïve CD4+ cells and peripheral Treg cells, CD44 and GFP were used (naïve cells: CD4+CD8GFPCD44low; Treg cells: CD4+CD8GFP+). The post-sort purity for each cell type was usually >95%.

Cell culture

FACS-sorted cells were cultured in complete RPMI-1640 medium (WelGENE, Daegu, Korea), supplemented with 10% fetal bovine serum (WelGENE), penicillin, streptomycin (Sigma-Aldrich, St. Louis, MO, USA), L-glutamine (2 mM; Life Technologies, Carlsbad, CA, USA), sodium pyruvate (2 mM; Sigma-Aldrich), nonessential amino acid (0.1 mM; Sigma-Aldrich) and 2-ME (50 μM; Sigma-Aldrich) (Heo et al. 2016).

Colitis model

Colitis was induced by FACS-purified naïve CD4+ T cells (CD4+CD44lowCD45RBhighGFP) either alone or in combination with Treg cells (CD4+GFP+) having different congenic marker (CD45.1 or CD45.2). Mice were weighed and monitored regularly for the signs of disease. Mice were sacrificed at 10 weeks after T cell transfer and their colons were used for histology.

Histology

Complete colons were fixed in formalin, processed, and stained with hematoxylin and eosin (H & E) or Periodic acid-Schiff (PAS). Blinded sections from the entire colon were examined.

Administration of anti-CD40 mAb

Mice were injected i.p. with 10 μg anti-CD40 (IC10; eBioscience) or rat IgG on days 0, 2, and 4 and sacrificed on day 6. Pooled peripheral LNs were analyzed by using the flow cytometry.

Chromatin immunoprecipitation

Chromatin immunoprecipitation (ChIP) analyses were done using EZ-ChIP kit (Milipore, Darmstadt, Germany). In brief, chromatin prepared from purified naive CD4+ T cells and CD4+GFP+ Treg cells was pre-cleared for 1 h with protein A agarose beads and then was incubated overnight with 2 μg rabbit anti-STAT5 (Santa Cruz Biotechnology, Dallas, TX, USA) or control rabbit anti-MyD88 (Santa Cruz Biotechnology). Immune complexes were precipitated with protein A agarose beads. Precipitated DNA was analyzed by real time PCR (Kim et al. 2014).

The sequences of primers are as below:

Tbx21 enhancer-Forward: 5’-CTTAGAAGGGGGTGGGTAGC-3’

Tbx21 enhancer-Reverse: 5’-GGACTGGAAAATCAGGCTCA-3’

Statistical analyses

A two-tailed, unpaired, student’s t-test was used to calculate the statistical significance of differences between groups unless specified. P values were represented as follows: ***P < .001; **P < .01; *P < .05, whereas NS, not significant, was used to denote P values >.05. Error bars indicate s.e.m.

Results

The expression of CXCR3 was reduced in Il2−/− Tregs

While we examined various surface and intracellular molecules in WT and Il2−/− Tregs with flow cytometry, we found that Il2−/− Tregs showed naïve phenotypes such as CD25low, CD103low, CTLA4low and CD44low in contrast to WT Tregs showing activated phenotypes (Figure 1(a)). Among these markers, we were interested in CXCR3, a chemokine receptor related with Th1 immune responses, which was downregulated in Il2−/− Tregs but not in conventional CD4+ T cells (Figure 1(b)). Consistent with a previous report (Koch et al. 2009), the chemokine receptor CXCR3 was found in about 15−20% of the WT Tregs. However, the frequency of CXCR3+ cells was significantly lower in Il2−/− Tregs (Figure 1(c)). The lack of CXCR3+ Tregs in Il2−/− mice suggests that CXCR3 expression is directly controlled by IL2, or there might be intrinsic defects in Th1 signaling molecules in Il2−/− Tregs. To distinguish these possibilities, we did adoptive transfer experiments. Tregs FACS-sorted from LNs of WT mice were injected into congenically marked Il2−/− mice and analyzed after 7 days. Flow cytometric analysis revealed that the frequency of CXCR3+ cells in the donor WT Tregs was still higher even in the Il2−/− host mice (Figure 1(d)) suggesting that Il2−/− Tregs have an intrinsic defect in CXCR3 expression. Because IFN-γ receptor (IFN-γR) and STAT-1 are known to promote the expression of CXCR3 (Koch et al. 2009), we compared the expression levels of CXCR3 in IL2, IFN-γR and double deficient Tregs. Indeed, the frequency of CXCR3+ Tregs was reduced the most in double deficient mice (Figure 1(e)). Furthermore, the expression level of IFN-γR was not altered in Il2−/− Tregs (Figure 1(f)) implying that CXCR3 was downregulated in the Il2−/− Tregs in an IFN-γR−independent and cell-intrinsic manner.

Figure 1. The expression of CXCR3 in Tregs is dependent on IL2. (a) Phenotypic analysis of Tregs in WT and Il2−/− mice. FACS plots are gated on CD4+Foxp3+ cells. (b) The frequencies of CXCR3+ cells in each population are shown. Gray, filled histograms are the results of the isotype control. (c) Results of the statistical analysis of (b), Bars show the mean ± SEM (n = 6−8, pooled from three independent experiments). (d) Congenically labeled WT Tregs were FACS-sorted and injected into Il2−/− mice. After 7 days, CXCR3 expression of the Tregs of donor or host origin was analyzed separately by flow cytometry. (e) CXCR3 expression in the Tregs of WT, Il2−/− (IL2KO), IFNγR deficient (Ifngr−/−, IFNγR-KO) and double deficient (Il2−/−Ifngr−/−, DKO) mice. (f) Flow cytometry showing the percentage of IFNγR-expressing cells in the CD4+ and Treg populations from WT and Il2−/− mice. Data are representative of three independent experiments (a, b, d, e, f). Numbers in the indicated area in the FACS plots refer to the percentage of each subset. ***P < .001; *P < .05; NS, not significant.

Il2−/− Tregs failed to upregulate T-bet under Th1 inflammations

Because T-bet has an essential role in CXCR3 expression in Tregs (Koch et al. 2009), we sought to investigate whether IL2 is involved in regulating the expression of T-bet in Tregs. T-bet is upregulated by specific cues associated with Th1 responses, and strong Th1 responses can be induced in vivo simply by injecting an agonistic anti-CD40 mAb (Ferlin et al. 1998), which led us to examine T-bet expression in WT and Il2−/− mice treated with anti-CD40 mAbs. As expected, the frequency of T-bet−expressing Tregs was increased in both WT and Il2−/− mice treated with anti-CD40 mAbs. However, the extent of upregulation of T-bet was much smaller in the Il2−/− Tregs (Figure 2(a)). We also did a FACS analysis on the expression of CXCR3 and found similar patterns (Figure 2(b)).

Figure 2. T-bet and CXCR3 were not upregulated in Il2−/− Tregs after anti-CD40 mAb treatment. Flow cytometric analysis of T-bet (a) and CXCR3 (b) in the Tregs of WT or Il2−/− mice treated with rat IgG (control) or anti-CD40 mAb. The first FACS plots are the isotype control samples. Data are representative of three independent experiments. Numbers in the indicated area in the FACS plots refer to the percentage of each subset.

IL2-STAT5 signals control the expressions of T-bet directly in Tregs

Next, we analyzed T-bet expression in Tregs after rIL2 treatment. Purified WT CD4+ naïve T cells and Tregs were cultured in the presence of rIL2 (2000 U/ml) overnight, and tbx21 transcripts were checked by quantitative PCR (qPCR). The level of tbx21 was not changed by the rIL2 treatment in naive CD4+ T cells (data not shown). In contrast, tbx21 expression in the Tregs increased after treatment with rIL2 (Figure 3(a)). Previously, IL2 was reported to facilitate Th1 cell differentiation by inducing T-bet in activated CD4+ T cells (Liao et al. 2011), which led us to examine whether IL2 upregulates T-bet directly via STAT5 in Tregs. Indeed, there was significantly more STAT5 bound to the tbx21 promoter locus in IL2−treated Tregs (Figure 3(b)). Altogether, these results imply that IL2 increases the expressions of T-bet directly via STAT5 enabling a subset of Tregs to be equipped with Th1 associated molecules including CXCR3.

Figure 3. The expression of T-bet in Tregs is controlled by the IL2−STAT5 signaling pathway. (a) FACS-sorted WT Tregs were treated with rIL2 (2000 U/ml) overnight in vitro, and RNAs extracted from each were subjected to qPCR analysis. The values were normalized to actin. The mean values ± SEM fold changes are shown. (b) ChIP analysis of STAT5 binding to the tbx21 promoter locus in WT naïve CD4+ T cells or Tregs cultured overnight with media (−) or rIL2 (+, 2000 U/ml). Each sample was immunoprecipitated with anti-STAT5 antibody, and bound DNA was amplified by qPCR for tbx21. Data are representative of three independent experiments. *P < .05; NS, not significant.

We next analyzed Th2 transcription factor GATA3 to examine whether IL2 has broader effects on the expressions of helper T cell lineage transcription factors, as shown in helper T cell differentiation (Liao et al. 2008; Liao et al. 2011), and found that GATA3 was also downregulated in Il2−/− Tregs (Figure 4). These results led us to hypothesize that IL2 might be required for genetic heterogeneity in Tregs (Campbell & Koch 2011) and help Tregs hold corresponding immune responses in check.

Figure 4. IL2 is essential for GATA3 expression in Tregs. GATA3 expression in WT and Il2−/− (KO) CD4+Foxp3 conventional T cells or CD4+Foxp3+ Tregs. Data are representative of three independent experiments. Numbers in the indicated area in the FACS plots refer to the percentage of each subset.

Impaired suppressive activity of Il2−/− Tregs

To examine the suppressive activity of Il2−/− Tregs in vitro, we did the in vitro suppression test. Cell division dye (eFluoro670)-labeled CD4+ responder cells were cocultured with antigen presenting cells, Tregs, and anti-CD3 mAbs, and the extent of proliferation of the responders was estimated after 3 days with flow cytometry. Because the dyes remain in non-dividing cells and are diluted in dividing cells, the frequency of dye+ responders indicates the suppressive activity of the Tregs. FACS-sorted Tregs (WT or Il2−/−) and WT naïve CD4+ T cells (responders) were mixed and stimulated by anti-CD3 mAbs in the presence of antigen presenting cells, and the proliferation of the responder cells was analyzed. Although the responders could produce IL2 and provide it to the Il2−/− Tregs, the suppressive function of the Il2−/− Tregs was impaired (Figure 5). Collectively, these results suggest that the immune regulatory functions of the Il2−/− Tregs might not be optimal especially under Th1 immune responses.

Figure 5. Analysis of suppressive functions in Il2−/− (KO) Tregs Responders were labeled with eFluoro670 and cultured in the presence or absence of anti-CD3 mAb and various doses of Tregs. Fluorescent intensity of eFluoro670 in responders was detected by flow cytometry after 3 days. Results of statistical analysis (right) are from a single experiment (duplicates, mean ± SEM) representative of three independent experiments.

Il2−/− Tregs failed to prevent colitis

Next, we analyzed the suppressive functions of Il2−/− Tregs in the colitis model (Haribhai et al. 2009). WT naïve CD4+ cells (5 × 105, CD45.1+CD45.2+) were transferred to Rag1 deficient mice either alone or in combination with 1.5 × 105 Tregs FACS-sorted from WT (CD45.1CD45.2+) or Il2−/− (CD45.1CD45.2+) mice (Figure 6(a)). The expression of Foxp3 was examined by intracellular staining, and >95% of the sorted Tregs expressed Foxp3 (Figure 6(a), lower). Recipient mice were sacrificed and analyzed by histological examination (for colonic inflammation) and flow cytometry (for phenotypic analysis) in 8−10 weeks. As described previously (Mottet et al. 2003), transfer of naïve CD4+ T cells resulted in clinical signs such as weight loss and histological changes. These abnormalities were ameliorated by co-transfer of WT Tregs. In contrast, mice that received Il2−/− Tregs developed colitis (Figure 6(b)) and intestinal inflammation (Figure 6(c)). Like the previous report that proinflammatory cytokine IFN-γ was associated with the pathogenesis of colitis (Xavier & Podolsky 2007), Il2−/− Tregs could not suppress IFN-γ production in pathogenic T cells (Figure 6(d)). To determine the mechanisms behind these results, we separated T cells according to the expression of congenic markers (CD45.1 and CD45.2) and analyzed them with flow cytometry. In both WT and Il2−/− Tregs, the expression levels of CD25, Foxp3 and Ki67 were not different (data not shown). However, the frequency of CD45.1CD45.2+ cells of Il2−/− Treg origin was much lower (Figure 6(e)) suggesting that the survival of the Il2−/− Tregs was impaired. Foxp3 proteins were also lost in some Il2−/− Tregs although the difference was not statistically significant (Figure 6(f)).

Figure 6. Il2−/− Tregs did not protect mice from colitis. (a) FACS-sorted WT naïve (CD45.1+CD45.2+), Tregs (CD45.1CD45.2+) and Il2−/− Tregs (CD45.1CD45.2+) were injected alone or together into Rag1 deficient (Rag−/−) mice. Recipient mice were examined after 8−10 weeks (left). FACS analysis scheme for the recipient mice is on the right side. (b) Rag1 deficient mice received either naïve T cells alone (black) or in combination with WT (white) or Il2−/− (KO, gray) Tregs, and were weighed weekly. The weight changes are shown as the mean ± SEM (n = 8, pooled from two independent experiments). (c) Representative histological sections of the colons from the mice in (b) stained with Hematoxylin and Eosin (H-E, upper) and Alcian blue and PAS (lower) to visualize goblet cells and mucus deposition. (d) Intracellular staining for IFN-γ in CD4+ T cells of naïve T cell origin (CD45.1+CD45.2+) after PMA/ionomycin stimulation. (e) The percentage of cells of Treg origin (CD45.1CD45.2+) in total transferred CD4+ T cells (CD4+TCRβ+). Results of statistical analysis are shown on the right side. Each symbol represents the result obtained from an individual recipient mouse; small horizontal lines indicate the mean values. (f) The percentage of Foxp3+ cells in the CD45.1CD45.2+ population (Treg origin). Results of statistical analysis are shown on the right side. Each symbol represents an individual recipient mouse; small horizontal lines indicate the mean values. mLN, mesenteric LN. Numbers in the indicated area in the FACS plots refer to the percentage of each subset. ***P < .001; *P < .05; NS, not significant.

Discussion

The importance of IL2 in Tregs is seen by the prominent autoimmunity that develops in Il2−/− mice. However, the underlying mechanism of how IL2 works in Tregs is still controversial. In this study, we showed that IL2 is required for the optimal expression of Th1 and Th2 transcription factors, T-bet and GATA3. Furthermore, Il2−/− Tregs showed inferior suppressive activity in the in vitro suppression test (Figure 5). These results led us to investigate the function of Il2−/− Tregs under Th1 inflammatory conditions, and we found that Il2−/− Tregs failed to control the corresponding immune pathology. Altogether, our results suggest that IL2 is required for the functional adaptation of Tregs, which helps to regulate various types of immune responses. Although we did not analyze Il2−/− Tregs under other conditions like Th2, Th17 and germinal centers, our results suggest that the suppressive activity of Il2−/− Tregs might be dysregulated in a context dependent manner.

Previously, it was reported that T-bet deficient Tregs did not survive well after transfer into scurfy mice (mice carrying the scurfy mutation in the Foxp3 alleles) and could not protect the recipient scurfy mice from Th1-mediated immune pathology implying that T-bet is required for the function and homeostasis of Tregs (Koch et al. 2009). However, it is not completely understood how Tregs can maintain the Foxp3-driven gene expression profiles in the presence of T-bet which encodes totally distinct programs. Recently, it was reported that the expression level of T-bet is 10–20 fold lower in Tregs than in conventional Th1 cells, and the Il12rb2 locus (encoding IL12 receptor β2, an essential Th1−associated cytokine receptor) is also epigenetically repressed in Tregs, which helps to maintain the low level of T-bet and prevents Tregs from completing Th1 differentiation programs (Koch et al. 2012). Then why do Tregs need T-bet despite the potential threats toward the Th1 lineage? Currently, we do not have any clear evidence or answers. However, given that both IL2 (Fontenot et al. 2005) and T-bet (Oestreich et al. 2014) are involved in the regulation of cell growth and metabolism and that the metabolic states of Tregs and Th1 are similar, we speculate that the interactions between IL2 and T-bet might be required for the metabolic fitness of Tregs (Galgani et al. 2016; Newton et al. 2016).

In conclusion, we showed that IL2 is required for the functional adaptation of Tregs to various environments by upregulating diverse tissue-specific transcription factors like T-bet. However, our findings also raise the question how do these transcription factors work together in Tregs and for what purpose.

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

This work was supported by the National Research Foundation of Korea [NRF-2013R1A1A2059821] and Hallym University [HRF-201612-016].

References

  • Belkaid Y. 2007. Regulatory T cells and infection: a dangerous necessity. Nat Rev Immunol. 7:875888. doi: 10.1038/nri2189 [Crossref], [PubMed], [Web of Science ®][Google Scholar]
  • Brunkow ME, Jeffery EW, Hjerrild KA, Paeper B, Clark LB, Yasayko SA, Wilkinson JE, Galas D, Ziegler SF, Ramsdell F. 2001. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet. 27:6873. doi: 10.1038/83784 [Crossref], [PubMed], [Web of Science ®][Google Scholar]
  • Campbell DJ, Koch MA. 2011. Phenotypical and functional specialization of FOXP3+ regulatory T cells. Nat Rev Immunol. 11:119130. doi: 10.1038/nri2916 [Crossref], [PubMed], [Web of Science ®][Google Scholar]
  • Cao X, Cai SF, Fehniger TA, Song J, Collins LI, Piwnica-Worms DR, Ley TJ. 2007. Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance. Immunity. 27:635646. doi: 10.1016/j.immuni.2007.08.014 [Crossref], [PubMed], [Web of Science ®][Google Scholar]
  • Chaudhry A, Rudra D, Treuting P, Samstein RM, Liang Y, Kas A, Rudensky AY. 2009. CD4+ regulatory T cells control TH17 responses in a Stat3-dependent manner. Science. 326:986991. doi: 10.1126/science.1172702 [Crossref], [PubMed], [Web of Science ®][Google Scholar]
  • Cheng G, Yu A, Dee MJ, Malek TR. 2013. IL-2R signaling is essential for functional maturation of regulatory T cells during thymic development. J Immunol. 190:15671575. doi: 10.4049/jimmunol.1201218 [Crossref], [PubMed], [Web of Science ®][Google Scholar]
  • Cheng G, Yu A, Malek TR. 2011. T-cell tolerance and the multi-functional role of IL-2R signaling in T-regulatory cells. Immunol Rev. 241:6376. doi: 10.1111/j.1600-065X.2011.01004.x [Crossref], [PubMed], [Web of Science ®][Google Scholar]
  • Choi JW, Lim HY, Chang MR, Cheon JY, Kim YS. 2008. Anti-tumor immunity induced by tumor cells express a membrane-bound form of IL-2 and SDF-1. Animal Cells Syst. 12:193201. doi: 10.1080/19768354.2008.9647173 [Taylor & Francis Online], [Web of Science ®][Google Scholar]
  • Cipolletta D, Feuerer M, Li A, Kamei N, Lee J, Shoelson SE, Benoist C, Mathis D. 2012. PPAR-gamma is a major driver of the accumulation and phenotype of adipose tissue Treg cells. Nature. 486:549553. [Crossref], [PubMed], [Web of Science ®][Google Scholar]
  • Ferlin WG, von der Weid T, Cottrez F, Ferrick DA, Coffman RL, Howard MC. 1998. The induction of a protective response in Leishmania major-infected BALB/c mice with anti-CD40 mAb. Eur J Immunol. 28:525531. doi: 10.1002/(SICI)1521-4141(199802)28:02<525::AID-IMMU525>3.0.CO;2-M [Crossref], [PubMed], [Web of Science ®][Google Scholar]
  • Fontenot JD, Rasmussen JP, Gavin MA, Rudensky AY. 2005. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat Immunol. 6:11421151. doi: 10.1038/ni1263 [Crossref], [PubMed], [Web of Science ®][Google Scholar]
  • Fu W, Ergun A, Lu T, Hill JA, Haxhinasto S, Fassett MS, Gazit R, Adoro S, Glimcher L, Chan S, et al. 2012. A multiply redundant genetic switch ‘locks in’ the transcriptional signature of regulatory T cells. Nat Immunol. 13:972980. doi: 10.1038/ni.2420 [Crossref], [PubMed], [Web of Science ®][Google Scholar]
  • Galgani M, De Rosa V, La Cava A, Matarese G. 2016. Role of metabolism in the immunobiology of regulatory T cells. J Immunol. 197:25672575. doi: 10.4049/jimmunol.1600242 [Crossref], [PubMed], [Web of Science ®][Google Scholar]
  • Haribhai D, Lin W, Edwards B, Ziegelbauer J, Salzman NH, Carlson MR, Li SH, Simpson PM, Chatila TA, Williams CB. 2009. A central role for induced regulatory T cells in tolerance induction in experimental colitis. J Immunol. 182:34613468. doi: 10.4049/jimmunol.0802535 [Crossref], [PubMed], [Web of Science ®][Google Scholar]
  • Heo JI, Kim JH, Lee JM, Kho YJ, Lim SS, Park JB, Kim J, Kim SC, Lee JY. 2016. FOXO3a activation by oxyresveratrol of Morus bombycis koidzumi extract mediates antioxidant activity. Animal Cells Syst. 20:3947. doi: 10.1080/19768354.2016.1143030 [Taylor & Francis Online], [Web of Science ®][Google Scholar]
  • Kim KB, Chae YC, Han A, Kang JY, Jung H, Park JW, Hahm JY, Kim S, Seo SB. 2014. Negative regulation of peroxiredoxin 6 (Prdx 6) transcription by nuclear oncoprotein DEK during leukemia cell differentiation. Animal Cells Syst. 18:318323. doi: 10.1080/19768354.2014.950605 [Taylor & Francis Online], [Web of Science ®][Google Scholar]
  • Koch MA, Thomas KR, Perdue NR, Smigiel KS, Srivastava S, Campbell DJ. 2012. T-bet(+) Treg cells undergo abortive Th1 cell differentiation due to impaired expression of IL-12 receptor beta2. Immunity. 37:501510. doi: 10.1016/j.immuni.2012.05.031 [Crossref], [PubMed], [Web of Science ®][Google Scholar]
  • Koch MA, Tucker-Heard G, Perdue NR, Killebrew JR, Urdahl KB, Campbell DJ. 2009. The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat Immunol. 10:595602. doi: 10.1038/ni.1731 [Crossref], [PubMed], [Web of Science ®][Google Scholar]
  • Liao W, Lin JX, Wang L, Li P, Leonard WJ. 2011. Modulation of cytokine receptors by IL-2 broadly regulates differentiation into helper T cell lineages. Nat Immunol. 12:551559. doi: 10.1038/ni.2030 [Crossref], [PubMed], [Web of Science ®][Google Scholar]
  • Liao W, Schones DE, Oh J, Cui Y, Cui K, Roh TY, Zhao K, Leonard WJ. 2008. Priming for T helper type 2 differentiation by interleukin 2-mediated induction of interleukin 4 receptor alpha-chain expression. Nat Immunol. 9:12881296. doi: 10.1038/ni.1656 [Crossref], [PubMed], [Web of Science ®][Google Scholar]
  • Malek TR. 2008. The biology of interleukin-2. Annu Rev Immunol. 26:453479. doi: 10.1146/annurev.immunol.26.021607.090357 [Crossref], [PubMed], [Web of Science ®][Google Scholar]
  • Malek TR, Castro I. 2010. Interleukin-2 receptor signaling: at the interface between tolerance and immunity. Immunity. 33:153165. doi: 10.1016/j.immuni.2010.08.004 [Crossref], [PubMed], [Web of Science ®][Google Scholar]
  • Mottet C, Uhlig HH, Powrie F. 2003. Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells. J Immunol. 170:39393943. doi: 10.4049/jimmunol.170.8.3939 [Crossref], [PubMed], [Web of Science ®][Google Scholar]
  • Newton R, Priyadharshini B, Turka LA. 2016. Immunometabolism of regulatory T cells. Nat Immunol. 17:618625. doi: 10.1038/ni.3466 [Crossref], [PubMed], [Web of Science ®][Google Scholar]
  • Oestreich KJ, Read KA, Gilbertson SE, Hough KP, McDonald PW, Krishnamoorthy V, Weinmann AS. 2014. Bcl-6 directly represses the gene program of the glycolysis pathway. Nat Immunol. 15:957964. doi: 10.1038/ni.2985 [Crossref], [PubMed], [Web of Science ®][Google Scholar]
  • Rubtsov YP, Rasmussen JP, Chi EY, Fontenot J, Castelli L, Ye X, Treuting P, Siewe L, Roers A, Henderson WR Jr., et al. 2008. Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity. 28:546558. doi: 10.1016/j.immuni.2008.02.017 [Crossref], [PubMed], [Web of Science ®][Google Scholar]
  • Sakaguchi S, Yamaguchi T, Nomura T, Ono M. 2008. Regulatory T cells and immune tolerance. Cell. 133:775787. doi: 10.1016/j.cell.2008.05.009 [Crossref], [PubMed], [Web of Science ®][Google Scholar]
  • Savage PA, Malchow S, Leventhal DS. 2013. Basic principles of tumor-associated regulatory T cell biology. Trends Immunol. 34:3340. doi: 10.1016/j.it.2012.08.005 [Crossref], [PubMed], [Web of Science ®][Google Scholar]
  • Schorle H, Holtschke T, Hunig T, Schimpl A, Horak I. 1991. Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature. 352:621624. doi: 10.1038/352621a0 [Crossref], [PubMed], [Web of Science ®][Google Scholar]
  • Wildin RS, Ramsdell F, Peake J, Faravelli F, Casanova JL, Buist N, Levy-Lahad E, Mazzella M, Goulet O, Perroni L, et al. 2001. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet. 27:1820. doi: 10.1038/83707 [Crossref], [PubMed], [Web of Science ®][Google Scholar]
  • Wing JB, Ise W, Kurosaki T, Sakaguchi S. 2014. Regulatory T cells control antigen-specific expansion of Tfh cell number and humoral immune responses via the coreceptor CTLA-4. Immunity. 41:10131025. doi: 10.1016/j.immuni.2014.12.006 [Crossref], [PubMed], [Web of Science ®][Google Scholar]
  • Xavier RJ, Podolsky DK. 2007. Unravelling the pathogenesis of inflammatory bowel disease. Nature. 448:427434. doi: 10.1038/nature06005 [Crossref], [PubMed], [Web of Science ®][Google Scholar]
  • Zheng Y, Chaudhry A, Kas A, de Roos P, Kim JM, Chu TT, Corcoran L, Treuting P, Klein U, Rudensky AY. 2009. Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses. Nature. 458:351356. doi: 10.1038/nature07674 [Crossref], [PubMed], [Web of Science ®][Google Scholar]
 

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.